A letter from Group Editorial Director, Megan L’Heureux, highlighting COVID-19 analysis, the announcement of Hashish Science and Expertise®’s partnership with Havas ECS, and the launch of our sister publication, Hashish Affected person Care™.
Blissful New Yr, readers! I believe we will all agree that 2020 was some of the difficult—if not essentially the most difficult—years we’ve ever confronted globally. Similar to lots of you, I used to be glad to show the calendar web page over to 2021, however sadly we’re nonetheless confronted with most of the similar challenges from final yr. Nevertheless, there have been quite a lot of wonderful scientific feats and triumphs alongside the best way. For instance, hashish analysis has led to some attention-grabbing developments associated to COVID-19 and preventing cytokine storms, as not too long ago highlighted in a few of our common columns and information protection (1,2). Scientific innovation was additionally mentioned in a letter from Mike Hennessy Sr, the founder and chairman of MJH Life Sciences—our mother or father firm (3). In his letter, Hennessy highlights the unbelievable work by the pharmaceutical trade to roll out a vaccine in simply 9 months. I believe we will all agree that this vaccine growth was an unbelievable scientific accomplishment that may hopefully permit us to come back again collectively at conferences and trade networking occasions in 2021.
Hashish Science and Expertise® has been doing its half to maintain you all linked as finest we will by our numerous webcasts and digital symposia. Final yr we held essentially the most occasions ever with roughly 20 webcasts and several other two-day digital symposia nicely as a number of half day symposiums. All of those occasions are free to attend and obtainable on demand for a full yr, so please go to https://www.cannabissciencetech.com/webcasts and join any occasions you might have missed reside.
We additionally not too long ago partnered with Havas ECS to supply a complete coaching curriculum for all ranges of scholars—from healthcare professionals to sufferers, dad and mom, caregivers, and budtenders. With three completely different course choices, you may select to be taught the fundamentals of the endocannabinoid system or earn persevering with medical training (CME) credit in both a 3-CME course or 12-CME course. Please go to our Programs web page to be taught extra: https://www.cannabissciencetech.com/courses
Final, however definitely not least, we launched a brand new sister publication targeted solely on medical hashish referred to as Hashish Affected person Care™ in November 2020 (4). This publication is an academic useful resource for sufferers, docs, nurses, pharmacists, and caregivers on the most recent analysis, advantages, and remedy choices hashish offers for quite a lot of sicknesses. Every situation of the publication will concentrate on a selected illness or ailment that hashish has been proven to be an efficient treatment for. Our mission is to teach the medical group on the viable remedy choices sufferers are experiencing with hashish and the continued analysis into hashish and cannabinoids worldwide. This yr we plan to publish
Hashish Affected person Care™ 4 instances—March, June, September, and November.
In 2021, Hashish Science and Expertise® will proceed our mission to teach the authorized hashish trade concerning the newest developments in analytical testing, high quality management/high quality assurance, cultivation, extraction, and processing/manufacturing. We hope you will see that the solutions and sources you want in our publication’s 9 points this yr. As at all times, if in case you have any concepts for content material or feedback please attain out to me. I really like to listen to from you!
Group Editorial Director
Learn how to Cite this Article
M. L’Heureux, Hashish Science and Expertise 4(1), 10 (2021).